Pyrimidine inhibitors synergize with nucleoside analogues to block SARS-CoV-2.
Nature
; 604(7904): 134-140, 2022 04.
Article
in En
| MEDLINE
| ID: mdl-35130559
Full text:
1
Database:
MEDLINE
Main subject:
Antiviral Agents
/
Pyrimidines
/
Drug Evaluation, Preclinical
/
SARS-CoV-2
/
Nucleosides
Type of study:
Guideline
Language:
En
Journal:
Nature
Year:
2022
Type:
Article
Affiliation country:
United States